{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["12-HHT, 12(S)-hydroxy-5-cis-8,10-trans-heptadecatrienoic acid", "5-H(p)ETE, 5-hydro(pero)xy-eicosatetraenoic acid", "COX, cyclooxygenase", "DAD, diode array detector", "DPPH, 2,2-diphenyl-1-picrylhydrazyl", "ECD, electronic circular dichroism", "ESI, electrospray ionization", "FCS, fetal calf serum", "HPLC, high performance liquid chromatography", "HR, high resolution", "IFN, interferon", "IL, interleukin", "Inflammation", "LOX, lipoxygenase", "LT, leukotriene", "LTC4S, leukotriene C4 synthase", "Lipid mediator", "Lipidomics", "Lipoxygenase", "MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide", "MaR, maresin", "Natural product", "PBMC, peripheral blood mononuclear cells", "PD, protectin", "PG, prostaglandin", "PMNL, polymorphonuclear neutrophils", "RP, reversed phase", "Resolution", "Rv, resolvin", "SPE, solid phase extraction", "SPM, specialized pro-resolving mediators", "TX, thromboxane", "UPLC\u2012MS/MS, ultra-performance liquid chromatography\u2013tandem mass spectrometry", "mPGES-1, microsomal prostaglandin E2 synthase 1", "sEH, soluble epoxide hydrolase"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34221873", "DateRevised": {"Year": "2024", "Month": "02", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "04", "Day": "20"}], "Language": ["eng"], "ELocationID": ["10.1016/j.apsb.2021.04.011"], "Journal": {"ISSN": "2211-3835", "JournalIssue": {"Volume": "11", "Issue": "6", "PubDate": {"Year": "2021", "Month": "Jun"}}, "Title": "Acta pharmaceutica Sinica. B", "ISOAbbreviation": "Acta Pharm Sin B"}, "ArticleTitle": "From Vietnamese plants to a biflavonoid that relieves inflammation by triggering the lipid mediator class switch to resolution.", "Pagination": {"StartPage": "1629", "EndPage": "1647", "MedlinePgn": "1629-1647"}, "Abstract": {"AbstractText": ["Chronic inflammation results from excessive pro-inflammatory signaling and the failure to resolve the inflammatory reaction. Lipid mediators orchestrate both the initiation and resolution of inflammation. Switching from pro-inflammatory to pro-resolving lipid mediator biosynthesis is considered as efficient strategy to relieve chronic inflammation, though drug candidates exhibiting such features are unknown. Starting from a library of Vietnamese medical plant extracts, we identified isomers of the biflavanoid 8-methylsocotrin-4'-ol from <i>Dracaena cambodiana</i>, which limit inflammation by targeting 5-lipoxygenase and switching the lipid mediator profile from leukotrienes to specialized pro-resolving mediators (SPM). Elucidation of the absolute configurations of 8-methylsocotrin-4'-ol revealed the 2<i>S</i>,<i>\u03b3S</i>-isomer being most active, and molecular docking studies suggest that the compound binds to an allosteric site between the 5-lipoxygenase subdomains. We identified additional subordinate targets within lipid mediator biosynthesis, including microsomal prostaglandin E<sub>2</sub> synthase-1. Leukotriene production is efficiently suppressed in activated human neutrophils, macrophages, and blood, while the induction of SPM biosynthesis is restricted to M2 macrophages. The shift from leukotrienes to SPM was also evident in mouse peritonitis <i>in\u00a0vivo</i> and accompanied by a substantial decrease in immune cell infiltration. In summary, we disclose a promising drug candidate that combines potent 5-lipoxygenase inhibition with the favorable reprogramming of lipid mediator profiles."], "CopyrightInformation": "\u00a9 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmacy/Pharmacognosy and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck 6020, Austria."}, {"Identifier": [], "Affiliation": "Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City 700000, Viet Nam."}], "LastName": "Van Anh", "ForeName": "Tran Thi", "Initials": "TT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmacy/Pharmacognosy and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck 6020, Austria."}], "LastName": "Mostafa", "ForeName": "Alilou", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Michael Popp Institute and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck 6020, Austria."}], "LastName": "Rao", "ForeName": "Zhigang", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, Jena 07743, Germany."}], "LastName": "Pace", "ForeName": "Simona", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmacy/Pharmacognosy and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck 6020, Austria."}], "LastName": "Schwaiger", "ForeName": "Stefan", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, Jena 07743, Germany."}], "LastName": "Kretzer", "ForeName": "Christian", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmacy/Pharmacognosy and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck 6020, Austria."}, {"Identifier": [], "Affiliation": "Institute of Pharmacy, Department of Pharmaceutical and Medicinal Chemistry, Paracelsus Medical University Salzburg, Salzburg 5020, Austria."}], "LastName": "Temml", "ForeName": "Veronika", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, Jena 07743, Germany."}], "LastName": "Giesel", "ForeName": "Carsten", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, Jena 07743, Germany."}], "LastName": "Jordan", "ForeName": "Paul M", "Initials": "PM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples 80131, Italy."}], "LastName": "Bilancia", "ForeName": "Rossella", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Transfusion Medicine, University Hospital Jena, Jena 07747, Germany."}], "LastName": "Weinigel", "ForeName": "Christina", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Transfusion Medicine, University Hospital Jena, Jena 07747, Germany."}], "LastName": "Rummler", "ForeName": "Silke", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmacy/Pharmacognosy and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck 6020, Austria."}], "LastName": "Waltenberger", "ForeName": "Birgit", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City 700000, Viet Nam."}], "LastName": "Hung", "ForeName": "Tran", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples 80131, Italy."}], "LastName": "Rossi", "ForeName": "Antonietta", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmacy/Pharmacognosy and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck 6020, Austria."}], "LastName": "Stuppner", "ForeName": "Hermann", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, Jena 07743, Germany."}], "LastName": "Werz", "ForeName": "Oliver", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Michael Popp Institute and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innsbruck 6020, Austria."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University Jena, Jena 07743, Germany."}], "LastName": "Koeberle", "ForeName": "Andreas", "Initials": "A"}], "GrantList": [{"GrantID": "T 942", "Acronym": "FWF_", "Agency": "Austrian Science Fund FWF", "Country": "Austria"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Acta Pharm Sin B", "NlmUniqueID": "101600560", "ISSNLinking": "2211-3835"}, "CoiStatement": "The authors declare no conflicts of interest. The above mentioned funding sources were neither involved in study design, data collection, analysis, and interpretation nor in writing and submission of the manuscript."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Pober J.S., Sessa W.C. Inflammation and the blood microvascular system. Cold Spring Harb Perspect Biol. 2014;7:a016345.", "ArticleIdList": ["PMC4292166", "25384307"]}, {"Citation": "Bennett M., Gilroy D. Lipid mediators in inflammation. In: Gordon S., editor. Myeloid cells in health and disease. ASM Press; Washington DC: 2017. pp. 343\u2013366."}, {"Citation": "Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001;294:1871\u20131875.", "ArticleIdList": ["11729303"]}, {"Citation": "Serhan C.N. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510:92\u2013101.", "ArticleIdList": ["PMC4263681", "24899309"]}, {"Citation": "Serhan C.N., Levy B.D. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest. 2018;128:2657\u20132669.", "ArticleIdList": ["PMC6025982", "29757195"]}, {"Citation": "Nathan C. Points of control in inflammation. Nature. 2002;420:846\u2013852.", "ArticleIdList": ["12490957"]}, {"Citation": "Haeggstr\u00f6m J.Z. Leukotriene biosynthetic enzymes as therapeutic targets. J Clin Invest. 2018;128:2680\u20132690.", "ArticleIdList": ["PMC6026001", "30108195"]}, {"Citation": "Turini M.E., DuBois R.N. Cyclooxygenase-2: a therapeutic target. Annu Rev Med. 2002;53:35\u201357.", "ArticleIdList": ["11818462"]}, {"Citation": "Sinha S., Doble M., Manju S.L. 5-Lipoxygenase as a drug target: a review on trends in inhibitors structural design, SAR and mechanism based approach. Bioorg Med Chem. 2019;27:3745\u20133759.", "ArticleIdList": ["31331653"]}, {"Citation": "Castellsague J., Riera-Guardia N., Calingaert B., Varas-Lorenzo C., Fourrier-Reglat A., Nicotra F. Individual NSAIDs and upper gastrointestinal complications. Drug Saf. 2012;35:1127\u20131146.", "ArticleIdList": ["PMC3714137", "23137151"]}, {"Citation": "Grosser T., Yu Y., FitzGerald G.A. Emotion recollected in tranquility: lessons learned from the COX-2 saga. Annu Rev Med. 2010;61:17\u201333.", "ArticleIdList": ["20059330"]}, {"Citation": "Koeberle A., Werz O. Inhibitors of the microsomal prostaglandin E2 synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)a critical review. Curr Med Chem. 2009;16:4274\u20134296.", "ArticleIdList": ["19754418"]}, {"Citation": "Su W.H., Cheng M.H., Lee W.L., Tsou T.S., Chang W.H., Chen C.S. Nonsteroidal anti-inflammatory drugs for wounds: pain relief or excessive scar formation?. Mediat Inflamm. 2010;2010:413238.", "ArticleIdList": ["PMC2910481", "20671960"]}, {"Citation": "Koeberle A., Laufer S.A., Werz O. Design and development of microsomal prostaglandin E2 synthase-1 inhibitors: challenges and future directions. J Med Chem. 2016;59:5970\u20135986.", "ArticleIdList": ["26791385"]}, {"Citation": "Samuelsson B., Morgenstern R., Jakobsson P.J. Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol Rev. 2007;59:207\u2013224.", "ArticleIdList": ["17878511"]}, {"Citation": "Ramsay R.R., Popovic-Nikolic M.R., Nikolic K., Uliassi E., Bolognesi M.L. A perspective on multi-target drug discovery and design for complex diseases. Clin Transl Med. 2018;7:3.", "ArticleIdList": ["PMC5770353", "29340951"]}, {"Citation": "Koeberle A., Werz O. Multi-target approach for natural products in inflammation. Drug Discov Today. 2014;19:1871\u20131882.", "ArticleIdList": ["25172801"]}, {"Citation": "Koeberle A., Werz O. Natural products as inhibitors of prostaglandin E2 and pro-inflammatory 5-lipoxygenase-derived lipid mediator biosynthesis. Biotechnol Adv. 2018;36:1709\u20131723.", "ArticleIdList": ["29454981"]}, {"Citation": "Fullerton J.N., Gilroy D.W. Resolution of inflammation: a new therapeutic frontier. Nat Rev Drug Discov. 2016;15:551\u2013567.", "ArticleIdList": ["27020098"]}, {"Citation": "Serhan C.N., Chiang N., Dalli J., Levy B.D. Lipid mediators in the resolution of inflammation. Cold Spring Harb Perspect Biol. 2014;7:a016311.", "ArticleIdList": ["PMC4315926", "25359497"]}, {"Citation": "Rao Z., Pace S., Jordan P.M., Bilancia R., Troisi F., Borner F. Vacuolar (H+)-ATPase critically regulates specialized proresolving mediator pathways in human M2-like monocyte-derived macrophages and has a crucial role in resolution of inflammation. J Immunol. 2019;203:1031\u20131043.", "ArticleIdList": ["PMC7347291", "31300512"]}, {"Citation": "Werz O., Gerstmeier J., Libreros S., De la Rosa X., Werner M., Norris P.C. Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity. Nat Commun. 2018;9:59.", "ArticleIdList": ["PMC5754355", "29302056"]}, {"Citation": "Newman D.J., Cragg G.M. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 2016;79:629\u2013661.", "ArticleIdList": ["26852623"]}, {"Citation": "Harvey A.L., Edrada-Ebel R., Quinn R.J. The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov. 2015;14:111\u2013129.", "ArticleIdList": ["25614221"]}, {"Citation": "Gilbert N.C., Gerstmeier J., Schexnaydre E.E., B\u00f6rner F., Garscha U., Neau D.B. Structural and mechanistic insights into 5-lipoxygenase inhibition by natural products. Nat Chem Biol. 2020;16:783\u2013790.", "ArticleIdList": ["PMC7747934", "32393899"]}, {"Citation": "Pein H., Ville A., Pace S., Temml V., Garscha U., Raasch M. Endogenous metabolites of vitamin E limit inflammation by targeting 5-lipoxygenase. Nat Commun. 2018;9:3834.", "ArticleIdList": ["PMC6148290", "30237488"]}, {"Citation": "Koeberle A., Munoz E., Appendino G.B., Minassi A., Pace S., Rossi A. SAR studies on curcumin's pro-inflammatory targets: discovery of prenylated pyrazolocurcuminoids as potent and selective novel inhibitors of 5-lipoxygenase. J Med Chem. 2014;57:5638\u20135648.", "ArticleIdList": ["24920381"]}, {"Citation": "Garscha U., Romp E., Pace S., Rossi A., Temml V., Schuster D. Pharmacological profile and efficiency in\u00a0vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase. Sci Rep. 2017;7:9398.", "ArticleIdList": ["PMC5571211", "28839250"]}, {"Citation": "Koeberle A., Siemoneit U., Buhring U., Northoff H., Laufer S., Albrecht W. Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1. J Pharmacol Exp Therapeut. 2008;326:975\u2013982.", "ArticleIdList": ["18550688"]}, {"Citation": "Hanke T., Dehm F., Liening S., Popella S.D., Maczewsky J., Pillong M. Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in\u00a0vivo. J Med Chem. 2013;56:9031\u20139044.", "ArticleIdList": ["24171493"]}, {"Citation": "Rossi A., Pergola C., Pace S., R\u00e5dmark O., Werz O., Sautebin L. In\u00a0vivo sex differences in leukotriene biosynthesis in zymosan-induced peritonitis. Pharmacol Res. 2014;87:1\u20137.", "ArticleIdList": ["24892983"]}, {"Citation": "Waltenberger B., Atanasov A.G., Heiss E.H., Bernhard D., Rollinger J.M., Breuss J.M. Drugs from nature targeting inflammation (DNTI): a successful Austrian interdisciplinary network project. Monatsh Chem. 2016;147:479\u2013491.", "ArticleIdList": ["PMC4785209", "27069281"]}, {"Citation": "Tran T.V.A., Malainer C., Schwaiger S., Hung T., Atanasov A.G., Heiss E.H. Screening of Vietnamese medicinal plants for NF-\u03baB signaling inhibitors: assessing the activity of flavonoids from the stem bark of Oroxylum indicum. J Ethnopharmacol. 2015;159:36\u201342.", "ArticleIdList": ["PMC4292993", "25456439"]}, {"Citation": "Dalli J., Serhan C.N. Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood. 2012;120:60\u201372.", "ArticleIdList": ["PMC3471524", "22904297"]}, {"Citation": "Ramon S., Dalli J., Sanger J.M., Winkler J.W., Aursnes M., Tungen J.E. The Protectin PCTR1 is produced by human M2 macrophages and enhances resolution of infectious inflammation. Am J Pathol. 2016;186:962\u2013973.", "ArticleIdList": ["PMC4822332", "26878209"]}, {"Citation": "Cash J.L., White G.E., Greaves D.R. Chapter 17. Zymosan-induced peritonitis as a simple experimental system for the study of inflammation. Methods Enzymol. 2009;461:379\u2013396.", "ArticleIdList": ["19480928"]}, {"Citation": "Gupta D., Bleakley B., Gupta R.K. Dragon's blood: botany, chemistry and therapeutic uses. J Ethnopharmacol. 2008;115:361\u2013380.", "ArticleIdList": ["18060708"]}, {"Citation": "Sun J., Liu J.N., Fan B., Chen X.N., Pang D.R., Zheng J. Phenolic constituents, pharmacological activities, quality control, and metabolism of Dracaena species: a review. J Ethnopharmacol. 2019;244:112138.", "ArticleIdList": ["31390529"]}, {"Citation": "Wang S.T., Chen S., Guo M., Liu X.M. Inhibitory effect of cochinchinenin B on capsaicin-activated responses in rat dorsal root ganglion neurons. Brain Res. 2008;1201:34\u201340.", "ArticleIdList": ["18294619"]}, {"Citation": "Guo M., Chen S., Liu X. Material basis for inhibition of Dragon's Blood on evoked discharges of wide dynamic range neurons in spinal dorsal horn of rats. Sci China C Life Sci. 2008;51:1025\u20131038.", "ArticleIdList": ["18989646"]}, {"Citation": "Ran Y., Wang R., Gao Q., Jia Q., Hasan M., Awan M.U. Dragon's blood and its extracts attenuate radiation-induced oxidative stress in mice. J Radiat Res. 2014;55:699\u2013706.", "ArticleIdList": ["PMC4100005", "24634306"]}, {"Citation": "Xin N., Li Y.J., Li X., Wang X., Li Y., Zhang X. Dragon's blood may have radioprotective effects in radiation-induced rat brain injury. Radiat Res. 2012;178:75\u201385.", "ArticleIdList": ["22686864"]}, {"Citation": "Ran Y., Wang R., Hasan M., Jia Q., Tang B., Shan S. Radioprotective effects of dragon's blood and its extracts on radiation-induced myelosuppressive mice. J Ethnopharmacol. 2014;154:624\u2013634.", "ArticleIdList": ["24814319"]}, {"Citation": "Ran Y., Wang R., Lin F., Hasan M., Jia Q., Tang B. Radioprotective effects of Dragon's blood and its extract against gamma irradiation in mouse bone marrow cells. Phys Med. 2014;30:427\u2013431.", "ArticleIdList": ["24360838"]}, {"Citation": "Namjoyan F., Kiashi F., Moosavi Z.B., Saffari F., Makhmalzadeh B.S. Efficacy of Dragon's blood cream on wound healing: a randomized, double-blind, placebo-controlled clinical trial. J Tradit Complement Med. 2015;6:37\u201340.", "ArticleIdList": ["PMC4737969", "26870678"]}, {"Citation": "Li Y.S., Wang J.X., Jia M.M., Liu M., Li X.J., Tang H.B. Dragon's blood inhibits chronic inflammatory and neuropathic pain responses by blocking the synthesis and release of substance P in rats. J Pharmacol Sci. 2012;118:43\u201354.", "ArticleIdList": ["22198006"]}, {"Citation": "Park K.A., Vasko M.R. Lipid mediators of sensitivity in sensory neurons. Trends Pharmacol Sci. 2005;26:571\u2013577.", "ArticleIdList": ["16185776"]}, {"Citation": "Chiang N., Fredman G., Backhed F., Oh S.F., Vickery T., Schmidt B.A. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature. 2012;484:524\u2013528.", "ArticleIdList": ["PMC3340015", "22538616"]}, {"Citation": "Gobbetti T., Dalli J., Colas R.A., Federici Canova D., Aursnes M., Bonnet D. Protectin D1n-3 DPA and resolvin D5n-3 DPA are effectors of intestinal protection. Proc Natl Acad Sci U S A. 2017;114:3963\u20133968.", "ArticleIdList": ["PMC5393238", "28356517"]}, {"Citation": "Hellmann J., Sansbury B.E., Wong B., Li X., Singh M., Nuutila K. Biosynthesis of D-series resolvins in skin provides insights into their role in tissue repair. J Invest Dermatol. 2018;138:2051\u20132060.", "ArticleIdList": ["PMC6109422", "29559341"]}, {"Citation": "Menon R., Krzyszczyk P., Berthiaume F. Pro-resolution potency of eesolvins D1, D2 and E1 on neutrophil migration and in dermal wound healing. Nano LIFE. 2017;7:1750002.", "ArticleIdList": ["PMC5851488", "29552232"]}, {"Citation": "Quiros M., Feier D., Birkl D., Agarwal R., Zhou D.W., Garcia A.J. Resolvin E1 is a pro-repair molecule that promotes intestinal epithelial wound healing. Proc Natl Acad Sci U S A. 2020;117:9477\u20139482.", "ArticleIdList": ["PMC7197018", "32300016"]}, {"Citation": "Zhu Y., Zhang P., Yu H., Li J., Wang M.W., Zhao W. Anti-Helicobacter pylori and thrombin inhibitory components from Chinese dragon's blood, Dracaena cochinchinensis. J Nat Prod. 2007;70:1570\u20131577.", "ArticleIdList": ["17883259"]}, {"Citation": "Sha Y., Shi Y., Niu B., Chen Q., Cochinchinenin C. A potential nonpolypeptide anti-diabetic drug, targets a glucagon-like peptide-1 receptor. RSC Adv. 2017;7:49015\u201349023."}, {"Citation": "Mahapatra D.K., Bharti S.K., Asati V. Chalcone Derivatives: anti-inflammatory potential and molecular targets perspectives. Curr Top Med Chem. 2017;17:3146\u20133169.", "ArticleIdList": ["28914193"]}, {"Citation": "Werz O. Inhibition of 5-lipoxygenase product synthesis by natural compounds of plant origin. Planta Med. 2007;73:1331\u20131357.", "ArticleIdList": ["17939102"]}, {"Citation": "Chen X., Qian K., Chen Q. Comparison between loureirin A and cochinchinenin C on the interaction with human serum albumin. Eur J Med Chem. 2015;93:492\u2013500.", "ArticleIdList": ["25734332"]}, {"Citation": "Werz O., Gerstmeier J., Garscha U. Novel leukotriene biosynthesis inhibitors (2012\u20122016) as anti-inflammatory agents. Expert Opin Ther Pat. 2017;27:607\u2013620.", "ArticleIdList": ["28005436"]}, {"Citation": "Pergola C., Werz O. 5-Lipoxygenase inhibitors: a review of recent\u00a0developments and patents. Expert Opin Ther Pat. 2010;20:355\u2013375.", "ArticleIdList": ["20180620"]}, {"Citation": "Zhou Y., Liu J., Zheng M., Zheng S., Jiang C., Zhou X. Structural optimization and biological evaluation of 1,5-disubstituted pyrazole-3-carboxamines as potent inhibitors of human 5-lipoxygenase. Acta Pharm Sin B. 2016;6:32\u201345.", "ArticleIdList": ["PMC4724694", "26904397"]}, {"Citation": "Bruno F., Spaziano G., Liparulo A., Roviezzo F., Nabavi S.M., Sureda A. Recent advances in the search for novel 5-lipoxygenase inhibitors for the treatment of asthma. Eur J Med Chem. 2018;153:65\u201372.", "ArticleIdList": ["29133059"]}, {"Citation": "Sorgi C.A., Zarini S., Martin S.A., Sanchez R.L., Scandiuzzi R.F., Gij\u00f3n M.A. Dormant 5-lipoxygenase in inflammatory macrophages is triggered by exogenous arachidonic acid. Sci Rep. 2017;7:10981.", "ArticleIdList": ["PMC5591212", "28887514"]}, {"Citation": "Peters-Golden M., Henderson W.R., Jr. Leukotrienes. N Engl J Med. 2007;357:1841\u20131854.", "ArticleIdList": ["17978293"]}, {"Citation": "Wynn T.A., Vannella K.M. Macrophages in tissue repair, regeneration, and fibrosis. Immunity. 2016;44:450\u2013462.", "ArticleIdList": ["PMC4794754", "26982353"]}, {"Citation": "Riendeau D., Percival M.D., Boyce S., Brideau C., Charleson S., Cromlish W. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol. 1997;121:105\u2013117.", "ArticleIdList": ["PMC1564640", "9146894"]}, {"Citation": "Riendeau D., Aspiotis R., Ethier D., Gareau Y., Grimm E.L., Guay J. Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886. Bioorg Med Chem Lett. 2005;15:3352\u20133355.", "ArticleIdList": ["15953724"]}, {"Citation": "de los Reyes Jim\u00e9nez M., Lechner A., Alessandrini F., Bohnacker S., Schindela S., Trompette A. An anti-inflammatory eicosanoid switch mediates the suppression of type-2 inflammation by helminth larval products. Sci Transl Med. 2020;12", "ArticleIdList": ["32321863"]}, {"Citation": "Levy B.D., Clish C.B., Schmidt B., Gronert K., Serhan C.N. Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol. 2001;2:612\u2013619.", "ArticleIdList": ["11429545"]}, {"Citation": "Ke Y., Zebda N., Oskolkova O., Afonyushkin T., Berdyshev E., Tian Y. Anti-inflammatory effects of OxPAPC involve endothelial cell-mediated generation of LXA4. Circ Res. 2017;121:244\u2013257.", "ArticleIdList": ["PMC5886749", "28522438"]}, {"Citation": "Samuelsson B., Dahlen S., Lindgren J., Rouzer C., Serhan C. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 1987;237:1171\u20131176.", "ArticleIdList": ["2820055"]}, {"Citation": "Siemoneit U., Pergola C., Jazzar B., Northoff H., Skarke C., Jauch J. On the interference of boswellic acids with 5-lipoxygenase: mechanistic studies in\u00a0vitro and pharmacological relevance. Eur J Pharmacol. 2009;606:246\u2013254.", "ArticleIdList": ["19374837"]}, {"Citation": "Cheung S.Y., Werner M., Esposito L., Troisi F., Cantone V., Liening S. Discovery of a benzenesulfonamide-based dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase that favorably modulates lipid mediator biosynthesis in inflammation. Eur J Med Chem. 2018;156:815\u2013830.", "ArticleIdList": ["30053720"]}, {"Citation": "Gerstmeier J., Seegers J., Witt F., Waltenberger B., Temml V., Rollinger J.M. Ginkgolic acid is a multi-target inhibitor of key enzymes in pro-inflammatory lipid mediator biosynthesis. Front Pharmacol. 2019;10:797.", "ArticleIdList": ["PMC6650749", "31379572"]}, {"Citation": "Gerstmeier J., Kretzer C., Di Micco S., Miek L., Butschek H., Cantone V. Novel benzoxanthene lignans that favorably modulate lipid mediator biosynthesis: a promising pharmacological strategy for anti-inflammatory therapy. Biochem Pharmacol. 2019;165:263\u2013274.", "ArticleIdList": ["30836057"]}, {"Citation": "Beck-Speier I., Oswald B., Maier K.L., Karg E., Ramseger R. Oxymetazoline inhibits and resolves inflammatory reactions in human neutrophils. J Pharmacol Sci. 2009;110:276\u2013284.", "ArticleIdList": ["PMC7128694", "19609065"]}, {"Citation": "Werner M., Jordan P.M., Romp E., Czapka A., Rao Z., Kretzer C. Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome. Faseb J. 2019;33:6140\u20136153.", "ArticleIdList": ["PMC6988863", "30735438"]}, {"Citation": "Radmark O., Werz O., Steinhilber D., Samuelsson B. 5-Lipoxygenase: regulation of expression and enzyme activity. Trends Biochem Sci. 2007;32:332\u2013341.", "ArticleIdList": ["17576065"]}, {"Citation": "Liu T., Xiang A., Peng T., Doran A.C., Tracey K.J., Barnes B.J. HMGB1\u2013C1q complexes regulate macrophage function by switching between leukotriene and specialized proresolving mediator biosynthesis. Proc Natl Acad Sci U S A. 2019;116:23254\u201323263.", "ArticleIdList": ["PMC6859319", "31570601"]}, {"Citation": "Mashima R., Okuyama T. The role of lipoxygenases in pathophysiology; new insights and future perspectives. Redox Biol. 2015;6:297\u2013310.", "ArticleIdList": ["PMC4556770", "26298204"]}, {"Citation": "Serhan C.N., Petasis N.A. Resolvins and protectins in inflammation resolution. Chem Rev. 2011;111:5922\u20135943.", "ArticleIdList": ["PMC3192290", "21766791"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "3", "Day": "4"}, {"Year": "2021", "Month": "4", "Day": "7"}, {"Year": "2021", "Month": "4", "Day": "7"}, {"Year": "2021", "Month": "7", "Day": "5", "Hour": "10", "Minute": "12"}, {"Year": "2021", "Month": "7", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "7", "Day": "6", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "4", "Day": "20"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34221873", "PMC8245855", "10.1016/j.apsb.2021.04.011", "S2211-3835(21)00138-6"]}}], "PubmedBookArticle": []}